Criteria

National Institutes of Health consensus development statement [1]​​

  • Classical phenylketonuria (PKU): a disorder associated with high levels of blood phenylalanine (phe) (typically >1211 micromol/L [20 mg/dL]) and a complete absence or profound deficiency of phenylalanine hydroxylase (PAH) activity.[1]​​

  • Non-PKU hyper-phenylalaninaemia: a lower elevation of blood phe.

  • Exclusion of tetrahydrobiopterin (BH4) deficiency states is not specifically mentioned in definition but assumed.

European classification[2]

  • Classical PKU: complete or near-complete deficiency of hepatic PAH activity accompanied in the patient by a dietary phe tolerance of <250-350 mg/day.

  • Moderate PKU: characterised by a dietary phe tolerance of 350-400 mg/day.

  • Mild PKU: characterised by a dietary phe tolerance of 400-600 mg/day.

  • Mild hyper-phenylalaninaemia: a condition in which plasma phe levels are <605 micromol/L (10 mg/dL) on a normal diet.

Common practice in the US

  • Classical PKU: blood phe on unrestricted diet >1211 micromol/L (20 mg/dL).

  • Non-PKU hyper-phenylalaninaemia:

    • Mild-to-moderate or non-classical PKU: blood phe on unrestricted diet above the threshold for triggering intervention but <1211 micromol/L (20 mg/dL).

    • Benign hyper-phenylalaninaemia: blood phe on unrestricted diet above normal but below the threshold for triggering intervention (typically the threshold is 363 micromol/L [6 mg/dL]).

Patients who have hyper-phenylalaninaemia resulting from rare defects in tetrahydrobiopterin synthesis or recycling are excluded from this definition.

Use of this content is subject to our disclaimer